Wisløff, T., Hagen, G., & Klemp, M. (2014). Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing.
استشهاد بنمط شيكاغوWisløff, Torbjørn, Gunhild Hagen, و Marianne Klemp. Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing, 2014.
MLA استشهادWisløff, Torbjørn, Gunhild Hagen, و Marianne Klemp. Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. Springer International Publishing, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.